Trials / Sponsors / NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Hea Heart Failure, Congestive | Phase 3 | 2007-08-01 |
| Completed | PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Ac Heart Failure, Congestive | Phase 3 | 2006-10-01 |
| Completed | PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Ac Heart Failure, Congestive | Phase 3 | 2006-08-01 |
| Completed | Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairm Heart Failure, Congestive, Renal Insufficiency | Phase 2 | 2005-09-01 |
| Completed | Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients Congestive Heart Failure, Renal Impairment | Phase 2 | 2004-12-01 |
| Completed | Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF). Heart Failure, Congestive | Phase 2 | 2004-08-01 |